Gladstone NOW: The Campaign Join Us on the Journey✕
Scientists at Gladstone Institutes have developed a thinking microscope powered by artificial intelligence (AI).
They can ask it to figure out what it takes to make sick cells with Parkinson’s disease behave like healthy ones. Beyond that goal, the scientists are not giving the microscope any instructions.
The microscope can independently trigger molecular changes in cells, watch what happens, and learn from the results. Without any human input, it designs new experiments and carries them out. Each one gets it closer to a potential therapy for Parkinson’s.
In this video, hear from Gladstone Investigator Steven Finkbeiner and Gladstone President Deepak Srivastava as they explain how the thinking microscope works, how it can accelerate science and discovery, and how it can ultimately be used to find new treatments for neurodegenerative diseases like Parkinson’s, Alzheimer’s, or ALS.
Gladstone NOW: The Campaign
Join Us On The Journey
Gladstone scientists have developed a thinking microscope that can conduct its own experiments, with the ultimate goal of treating neurodegenerative diseases.
Finkbeiner Lab AI Center for Systems and Therapeutics Neurological Disease Alzheimer’s Disease Parkinson’s Disease ALS Huntington’s DiseaseThe center, funded by an NIH grant, will become one of three national centers dedicated to accelerating the development of phage therapy.
News Release Grants Data Science and Biotechnology Infectious Disease Shipman Lab Pollard Lab Ott Lab Silas Lab AIA new study upends long-held view about how DNA is stored, explaining how subtle shifts in gene activity contribute to cancer, aging, and other complex diseases.
News Release Research (Publication) Cancer Data Science and Biotechnology Ramani Lab Aging AI